Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-27 4:05 pm Purchase | 2022-05-17 | 13G | GH RESH PLC SHS GHRS | Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% | 2,820,501 (New Position) | Filing History |
| 2022-05-25 5:23 pm Purchase | 2022-05-15 | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners II, L.P. | 1,657,733 9.990% | 1,657,733 (New Position) | Filing History |
| 2022-05-23 4:30 pm Purchase | 2022-05-12 | 13G | AKOUOS INC AKUS | Venrock Healthcare Capital Partners II, L.P. | 2,391,545 6.900% | 2,391,545 (New Position) | Filing History |
| 2022-04-29 4:05 pm Purchase | 2022-04-19 | 13G | INOZYME PHARMA INC INZY | Venrock Healthcare Capital Partners II, L.P. | 4,065,000 9.800% | 4,065,000 (New Position) | Filing History |
| 2022-04-22 4:05 pm Purchase | 2022-04-12 | 13G | LYRA THERAPEUTICS INC LYRA | Venrock Healthcare Capital Partners II, L.P. | 68,661 9.999% | 68,661 (New Position) | Filing History |
| 2022-04-21 4:05 pm Purchase | 2022-04-11 | 13G | TREVI THERAPEUTICS INC TRVI | Venrock Healthcare Capital Partners II, L.P. | 3,668,334 9.990% | 3,668,334 (New Position) | Filing History |
| 2022-02-14 4:21 pm Purchase | 2021-12-31 | 13G | SIERRA ONCOLOGY INC SRRA | Venrock Healthcare Capital Partners II, L.P. | 984,746 6.100% | 777,509 (+375.18%) | Filing History |
| 2022-02-14 4:20 pm Sale | 2021-12-31 | 13G | ALTIMMUNE INC ALT | Venrock Healthcare Capital Partners II, L.P. | 1,760,870 4.200% | -1,862,094 (-51.40%) | Filing History |
| 2022-02-14 4:20 pm Purchase | 2021-12-31 | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II, L.P. | 534,910 8.000% | 60,235 (+12.69%) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-11-17 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 3,494,851 6.300% | 3,494,851 (New Position) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-03-26 | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II, L.P. | 2,270,072 8.200% | 1,601,632 (+239.61%) | Filing History |
| 2022-02-14 4:18 pm Purchase | 2021-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II, L.P. | 2,880,096 7.800% | 291,155 (+11.25%) | Filing History |
| 2022-02-14 4:17 pm Sale | 2021-12-31 | 13G | ATYR PHARMA INC ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,565,000 5.600% | -250,000 (-13.77%) | Filing History |
| 2022-02-14 4:15 pm Sale | 2021-12-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Venrock Healthcare Capital Partners II, L.P. | 250,000 0.500% | -3,177,461 (-92.71%) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II, L.P. | 4,302,126 9.990% | -53,147 (-1.22%) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II, L.P. | 100,000 2.700% | -69,162 (-40.89%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-01-19 | 13G | ACLARIS THERAPEUTICS INC ACRS | Venrock Healthcare Capital Partners II, L.P. | 4,563,962 7.500% | 4,563,962 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-08-26 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | Venrock Healthcare Capital Partners II, L.P. | 1,529,402 7.300% | 1,529,402 (New Position) | Filing History |
| 2021-11-10 4:05 pm Purchase | 2021-10-31 | 13G | LIANBIO SPONSORED ADS LIANY | Venrock Healthcare Capital Partners II, L.P. | 5,378,341 5.100% | 5,378,341 (New Position) | Filing History |
| 2021-09-30 4:05 pm Purchase | 2021-09-20 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Venrock Healthcare Capital Partners II, L.P. | 3,427,461 8.100% | 3,427,461 (New Position) | Filing History |